跳至主要内容
临床试验/DRKS00033322
DRKS00033322已完成不适用

Prospective evaluation of an artificial intelligence (AI)-assisted, software-based (Quantib®Prostate) reporting of multiparametric magnetic resonance imaging (MRI) in the context of MRI/ultrasound fusion biopsies of the prostate

Vivantes Klinikum Am Urban0 个研究点目标入组 262 人开始时间: 2023年12月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
262

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Male

入选标准

  • patients with an mpMRI of the prostate (T2, DWI and, if applicable, DCE sequences) who are suitable for evaluation with the Quantib®Prostate AI software and who subsequently undergo an MRI/US fusion biopsy of the prostate with needle tracking at the urology clinic of Vivantes Klinikum Am Urban.

排除标准

  • - inadequate image quality of the mpMRI
  • - missing mpMRI before biopsy
  • - missing mpMRI sequences for analysis by the AI software
  • - premature termination of the prostate biopsy or insufficient histological material for subsequent analyses

研究者

发起方
Vivantes Klinikum Am Urban

相似试验